With up to $6.8 million in funding, USC researchers will develop an AI-driven framework to strengthen how evidence is generated for gene and cell therapies, helping to bring promising treatments closer to patients.
New research by USC Marshall’s John Matsusaka shows how the agency’s informal regulatory guidance can hurt investors — without any obvious positive tradeoffs.
From patches that restore vision to compounds that kill brain tumors, drug & device discoveries by USC researchers are reaching patients faster than ever before.
The research team created a new AI-powered tool that identifies and quantifies the part of the brain that connects the hemispheres.
The chemical commonly known as PCE, which is found in consumer products and used in dry cleaning, is shown to triple the risk of liver fibrosis.
The chemical commonly known as PCE, which is found in consumer products and used in dry cleaning, is shown to triple the risk of liver fibrosis.
USC physician-scientists Denis Evseenko and Toby Maher are working on a regenerative drug to block the cells that promote fibrosis, or scarring, in the lungs.
A comprehensive literature review from USC and UCLA researchers analyzed the evidence on viscoelastic testing, which can help assess blood clotting during postpartum hemorrhage, and explored the path to its adoption in the U.S.
Scientists create “assembloids,” the most mature and complex kidney structures ever grown in a lab and a tool for developing new therapies.
USC research finds that Americans with less education are aging faster biologically than their peers with more schooling. The gap has grown over the last 30 years.
